AMWL Stock Recent News

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.

BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell.

American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The consensus price target hints at a 46.5% upside potential for American Well (AMWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here is how American Well Corporation (AMWL) and Claritev Corporation (CTEV) have performed compared to their sector so far this year.

The headline numbers for American Well (AMWL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

American Well Corporation (NYSE:AMWL ) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Charles Rhyee - TD Cowen Jailendra Singh - Truist Stan Berenshteyn - Wells Fargo Securities LLC Eric Percher - Nephron David Larsen - BTIG Matt Shea - Needham Operator Good day, and thank you for standing by. Welcome to Amwell's First Quarter 2025 Earnings Conference Call.

American Well Corporation (AMWL) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to loss of $5 per share a year ago.

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report.